Despite the benchmark S&P 500 ( SP500 ) continuing to rally this week, underlying market breadth has weakened, highlighting a growing divergence beneath the surface of the broader advance. While the index now trades roughly 8% above its 50-day moving average, a larger share of individual components are flashing oversold conditions rather than overbought signals. Current market data shows that 36.8...
Despite the benchmark S&P 500 ( SP500 ) continuing to rally this week, underlying market breadth has weakened, highlighting a growing divergence beneath the surface of the broader advance. While the index now trades roughly 8% above its 50-day moving average, a larger share of individual components are flashing oversold conditions rather than overbought signals. Current market data shows that 36.8% of S&P 500 stocks are considered oversold, compared with just 29.8% categorized as overbought. The imbalance suggests that gains in the benchmark index are being driven by a smaller group of outperforming stocks, while the average constituent has struggled to maintain upward momentum. The disconnect between headline index performance and internal participation may signal narrowing leadership, a trend investors often monitor closely for clues about the durability of broader market strength. Outlined below are the top 10 most oversold S&P 500 stocks according to the RSI indicator: Zoetis ( ZTS ), 15.09 RSI. EPAM Systems ( EPAM ), 20.13 RSI. Tractor Supply ( TSCO ), 20.99 RSI. Cognizant Technology Solutions ( CTSH ), 23.46 RSI. Danaher ( DHR ), 23.77 RSI. Lululemon Athletica ( LULU ), 25.09 RSI. Leidos Holdings ( LDOS ), 25.17 RSI. Pool Corp. ( POOL ), 25.26 RSI. Trimble ( TRMB ), 25.47 RSI. Northrop Grumman ( NOC ), 25.72 RSI. S&P 500 Funds: ( SPY ), ( VOO ), ( IVV ), ( RSP ), ( SSO ), ( UPRO ), ( SH ), ( SDS ), ( SPXU ), ( FXAIX ), ( VFIAX ), ( VFFSX ), and ( SWPPX ). More on markets Dividend Roundup: Chevron, 3M, Lockheed Martin, Carnival Corporation, and more Treasury yields surge toward one-year highs as inflation fears grip Wall Street Top 20 stocks fueling the S&P 500 north of 7,500 Dow crosses 50K and these 10 names have been the index's YTD leaders Fed’s favorite inflation gauge seen running at more than double target rate
Sundry Photography/iStock Editorial via Getty Images Article Thesis Cisco Systems ( CSCO ) has reported strong earnings results, which propelled its stock higher -- continuing a strong upward trend over the last couple of months. While Cisco benefits from AI infrastructure investment tailwinds that should positively impact its growth rate in the foreseeable future, the strong share price gains hav...
Sundry Photography/iStock Editorial via Getty Images Article Thesis Cisco Systems ( CSCO ) has reported strong earnings results, which propelled its stock higher -- continuing a strong upward trend over the last couple of months. While Cisco benefits from AI infrastructure investment tailwinds that should positively impact its growth rate in the foreseeable future, the strong share price gains have made its stock more expensive than it used to be -- so maybe it's not a great investment right now. Past Coverage I have written about Cisco Systems here on Seeking Alpha in the past, most recently in the fall of 2025, when I published this article . I was bullish on CSCO back then and recommended it as a Buy -- so far, this has worked out very well, with CSCO returning 50% in around six months, way more than the broad market's ~10% return over the same time frame. With Cisco Systems reporting its most recent earnings results on Wednesday, and with my most recent coverage being from half a year ago, I want to update my views on CSCO today. What Happened? On Wednesday, Cisco Systems did what many other tech companies did over the last couple of weeks -- it reported stronger-than-expected earnings results . These were the headline numbers: Cisco Systems fiscal Q3 earnings results (Seeking Alpha) As we can see in the above screencap, CSCO beat the analyst consensus on both lines, with a ~2% beat for both its revenues and its earnings per share. The market reacted very positively to that, sending CSCO up by 13% on the day following the earnings release. I believe that this is a little overblown -- results were good, but not so outstanding that a double-digit move on top of an already strong performance in recent weeks was justified. Cisco Systems: AI Infrastructure Spending Beneficiary Let's delve into the company's results. Starting with Cisco's top line, we see a growth rate of 12% compared to one year earlier -- not an outstanding growth rate compared to what some other te...
According to an SEC filing dated May 14, 2026, Lane Generational LLC reported acquiring 182,575 shares of GitLab (NASDAQ:GTLB) in the first quarter. The estimated value of the trade was $5.33 million, calculated using the average closing price during the first quarter of 2026. At quarter-end, the position was valued at $3.95 million, reflecting both the new stake and changes in the share price ove...
According to an SEC filing dated May 14, 2026, Lane Generational LLC reported acquiring 182,575 shares of GitLab (NASDAQ:GTLB) in the first quarter. The estimated value of the trade was $5.33 million, calculated using the average closing price during the first quarter of 2026. At quarter-end, the position was valued at $3.95 million, reflecting both the new stake and changes in the share price over the period. GitLab is a leading provider of DevOps lifecycle software. Its integrated platform streamlines software development and deployment for organizations seeking efficiency and security. The company’s single-application approach enables clients to accelerate innovation and improve visibility across the development process. Continue reading
The VictoryShares US Large Cap High Div Volatility Wtd ETF (NASDAQ:CDL) pulls its distribution from dividends paid by large U.S. companies that have screened in for both yield and lower realized volatility. CDL is volatility weighted rather than market-cap weighted (the index methodology pushes back against market-cap concentration risk), which means a handful of regulated ... CDL Delivers Capital...
The VictoryShares US Large Cap High Div Volatility Wtd ETF (NASDAQ:CDL) pulls its distribution from dividends paid by large U.S. companies that have screened in for both yield and lower realized volatility. CDL is volatility weighted rather than market-cap weighted (the index methodology pushes back against market-cap concentration risk), which means a handful of regulated ... CDL Delivers Capital Gains Alongside Income as Rates Hover Near 4.4%
Just_Super/E+ via Getty Images Introduction Since I last covered Hims & Hers Health ( HIMS ) in March, two main things have happened: more clarity on peptides and Q1-26 earnings were released after the bell on Monday. There is no shortage of coverage claiming Q1 was "disastrous," but this is objectively not true and simply not rooted in reality. It seems to me that many of the investors making the...
Just_Super/E+ via Getty Images Introduction Since I last covered Hims & Hers Health ( HIMS ) in March, two main things have happened: more clarity on peptides and Q1-26 earnings were released after the bell on Monday. There is no shortage of coverage claiming Q1 was "disastrous," but this is objectively not true and simply not rooted in reality. It seems to me that many of the investors making these claims are reacting emotionally and framing the quarter far more negatively than the underlying results justify, seemingly in hopes that sentiment will reverse and erase recent losses. I have stated many times that the stock market is not for the faint of heart, is unforgiving to those who are impatient, and demands conviction. For the rest of this piece, I only ask of you two things: An open mind An erased memory Specifically, read the piece as if you were not an investor, and most importantly, pretend HIMS has no stock price. Combined, this will allow us to interpret the quarter in reality, without biases or emotion. By the end, I will present the case on why the stock is worth over $100 per share. The Facts and Reality of Q1 2026 Fact 1 : Total revenue grew 4% YoY, a product of international growth masking a domestic decline in sales of 8% YoY. Reality : Q1-26 was the worst quarter in the company's history from a PR perspective—sued by Novo Nordisk ( NVO ), targeted by the FDA, investigated by the DOJ, subject to SEC inquiry, and probably probed by the Lackawanna County Sheriff's office. Okay, the last one's a joke (where are my Office fans?). Q1-25 was a blockbuster quarter as GLP-1s came to the platform and sold like hotcakes. Thus, the YoY comparison is not really fair, as you'd be comparing the best quarter to the worst quarter. I'm not saying Q1-26 was spectacular (it wasn't); I'm just saying we have to put things into perspective. Fact 2 : Margins decreased from roughly 73% to 65%. Reality : The switch in the company's business model from selling compounded GLP-...
Getty Images Olema Pharmaceuticals ( OLMA ) published decent trial results in October last year, but the stock dropped ~30%. Then Roche published its own trial data in November, and the stock more than tripled—only to go down again in March when Roche published data from another trial. Look at the chart below: Seeking Alpha, Author The chart tells the entire endocrine-therapy story quite clearly. ...
Getty Images Olema Pharmaceuticals ( OLMA ) published decent trial results in October last year, but the stock dropped ~30%. Then Roche published its own trial data in November, and the stock more than tripled—only to go down again in March when Roche published data from another trial. Look at the chart below: Seeking Alpha, Author The chart tells the entire endocrine-therapy story quite clearly. Before November 2025, OLMA traded like a largely ignored early-stage oncology company. Avisol, with whom I collaborate, actually wrote an article on Olema whose title – “ interesting but undifferentiated ” – clearly captures the prevailing sentiment about oral SERDs/CERANs. The market was so disinterested that even quite decent data from Palazestrant's phase 1/2 study failed to move the stock out of its torpor. Investors remained skeptical whether another endocrine therapy could outperform existing standards. Roche’s positive lidERA readout on November 18 changed all that. OLMA stock immediately repriced, entering an entirely different valuation range. The debate shifted from whether next-generation ER antagonists worked at all to which companies might win the category. Since palazestrant already had solid Phase 1/2 data, Olema could even more strongly claim its mechanistic differentiation from other SERDs. Using Roche’s game changing data, it could point to its own upcoming pivotal studies as validation for the repricing. Then came the failure of persevERA on March 9, and the sector was brought down to reality. Giredestrant failed to achieve statistically significant PFS improvement in the frontline endocrine-sensitive metastatic setting. That reminded investors that SERD biology is more complicated than a simple “the better SERD shall win” heuristic. There was a sharp decline in OLMA, as if the market now believed it had been wrong in extrapolating lidERA too aggressively across all settings. The current chart actually strengthens a speculative Buy case. It is now more ba...
Pakistan is keen to raise more money from China’s onshore markets this year after the country successfully issued its debut yuan-denominated notes, according to Finance Minister Muhammad Aurangzeb . The South Asian country’s maiden issuance was more than five times oversubscribed, pointing to robust investor appetite for the bonds. The country has successfully raised $258 million from the debt sal...
Pakistan is keen to raise more money from China’s onshore markets this year after the country successfully issued its debut yuan-denominated notes, according to Finance Minister Muhammad Aurangzeb . The South Asian country’s maiden issuance was more than five times oversubscribed, pointing to robust investor appetite for the bonds. The country has successfully raised $258 million from the debt sale, marking its cheapest foreign-currency bond offering ever. “We are very clear that this is not a single event,” he said in an interview on Friday. The overall size of the panda bond program is $1 billion, he said. “We are going to go ahead with the RMB issuances for the next tranche right away.” Pakistan has successfully raised money from international markets this year. It also sold a global bond for the first time in four years in a private placement last month. The country has undertaken economic reforms under programs with the International Monetary Fund, restoring investor confidence after coming close to a default in 2023.
Hispanolistic/E+ via Getty Images Thesis Summary Back in April, I argued that the market had forgotten about NVIDIA Corporation ( NVDA ). At the time, the stock had gone nowhere for months despite AI demand continuing to surge and GPU rental pricing moving higher again. But since then, Nvidia has started to wake up, rallying strongly along with other semiconductor stocks. However, Nvidia still has...
Hispanolistic/E+ via Getty Images Thesis Summary Back in April, I argued that the market had forgotten about NVIDIA Corporation ( NVDA ). At the time, the stock had gone nowhere for months despite AI demand continuing to surge and GPU rental pricing moving higher again. But since then, Nvidia has started to wake up, rallying strongly along with other semiconductor stocks. However, Nvidia still has one major catalyst ahead that could catapult it even further: Q1 earnings AI demand is accelerating, demand from China could return in a big way, and I have high expectations for what Nvidia has in store. This earnings report could remind the market why there is only one Nvidia. Following Up On My Last Nvidia Thesis In my previous article, I argued that Nvidia's stagnation was temporary. NVDA vs Peers (SA) And while the king of GPUs has still lagged competitors like Advanced Micro Devices ( AMD ) and Intel ( INTC ), it's begun to join the rally with force. Importantly, many of the bullish indicators we discussed back then have actually strengthened. GPU rental pricing remains elevated across the market, and AI hyperscaler spending continues to ramp aggressively. We can see proof of this across various earnings reports from companies in the sector, like AMD and Nebius ( NBIS ) Now, NVIDIA has two clear catalysts that should help the stock play catch-up with its competitors. Chinese Demand Is Quietly Returning Perhaps the biggest development ahead of earnings is China. China used to be one of Nvidia's biggest clients, but this changed due to export restrictions. However, there's now a very real possibility that sales to China of the H200 could resume . Nvidia CEO Jensen Huang accompanied Trump to China recently, and it seems like the meeting was quite constructive. Despite all the geopolitical noise, Chinese firms still want Nvidia GPUs because they are arguably the best out there. Let's crunch some numbers. Reuters recently reported that China had approved purchases of over...
Hispanolistic/E+ via Getty Images Thesis Summary Back in April, I argued that the market had forgotten about NVIDIA Corporation ( NVDA ). At the time, the stock had gone nowhere for months despite AI demand continuing to surge and GPU rental pricing moving higher again. But since then, Nvidia has started to wake up, rallying strongly along with other semiconductor stocks. However, Nvidia still has...
Hispanolistic/E+ via Getty Images Thesis Summary Back in April, I argued that the market had forgotten about NVIDIA Corporation ( NVDA ). At the time, the stock had gone nowhere for months despite AI demand continuing to surge and GPU rental pricing moving higher again. But since then, Nvidia has started to wake up, rallying strongly along with other semiconductor stocks. However, Nvidia still has one major catalyst ahead that could catapult it even further: Q1 earnings AI demand is accelerating, demand from China could return in a big way, and I have high expectations for what Nvidia has in store. This earnings report could remind the market why there is only one Nvidia. Following Up On My Last Nvidia Thesis In my previous article, I argued that Nvidia's stagnation was temporary. NVDA vs Peers (SA) And while the king of GPUs has still lagged competitors like Advanced Micro Devices ( AMD ) and Intel ( INTC ), it's begun to join the rally with force. Importantly, many of the bullish indicators we discussed back then have actually strengthened. GPU rental pricing remains elevated across the market, and AI hyperscaler spending continues to ramp aggressively. We can see proof of this across various earnings reports from companies in the sector, like AMD and Nebius ( NBIS ) Now, NVIDIA has two clear catalysts that should help the stock play catch-up with its competitors. Chinese Demand Is Quietly Returning Perhaps the biggest development ahead of earnings is China. China used to be one of Nvidia's biggest clients, but this changed due to export restrictions. However, there's now a very real possibility that sales to China of the H200 could resume . Nvidia CEO Jensen Huang accompanied Trump to China recently, and it seems like the meeting was quite constructive. Despite all the geopolitical noise, Chinese firms still want Nvidia GPUs because they are arguably the best out there. Let's crunch some numbers. Reuters recently reported that China had approved purchases of over...
The semiconductor sector is selling off at the open on Friday, with all three major U.S.-listed chipmakers giving back a slice of their parabolic spring rallies. Intel (NASDAQ:INTC) shares are leading the move lower, sliding 8% in early trading to $108 from Thursday’s close of $115.93. Advanced Micro Devices (NASDAQ:AMD) stock is down 4% to ... Intel Slumps 7%, AMD and NVIDIA Slide 4% in Chipmaker...
The semiconductor sector is selling off at the open on Friday, with all three major U.S.-listed chipmakers giving back a slice of their parabolic spring rallies. Intel (NASDAQ:INTC) shares are leading the move lower, sliding 8% in early trading to $108 from Thursday’s close of $115.93. Advanced Micro Devices (NASDAQ:AMD) stock is down 4% to ... Intel Slumps 7%, AMD and NVIDIA Slide 4% in Chipmaker Selloff
Nadya So Starbucks ( SBUX ) is eliminating another 300 corporate positions and closing some regional offices amid a push to streamline the organization, reduce operational complexity, and create a more profitable business, marking the third round of layoffs since last year. In a filing with the U.S. Securities and Exchange Commission on Friday, Starbucks ( SBUX ) confirmed that the board approved ...
Nadya So Starbucks ( SBUX ) is eliminating another 300 corporate positions and closing some regional offices amid a push to streamline the organization, reduce operational complexity, and create a more profitable business, marking the third round of layoffs since last year. In a filing with the U.S. Securities and Exchange Commission on Friday, Starbucks ( SBUX ) confirmed that the board approved further actions under its “Back to Starbucks” strategy to pursue $2B in cost-savings initiatives, with a majority to be completed by the end of this fiscal year. Of the ~$400M of restructuring charges to be incurred, ~$280M will be non-cash charges due to impairment of long-lived assets, and the remaining $120M will be cash charges tied to the workforce reduction. The latest round of layoffs will impact corporate roles in Seattle and remote positions located around the U.S. The company recently announced plans to open a new $100M corporate office in Nashville, which will employ 2K employees, mostly in technology and supply chain positions. At the same time, Starbucks ( SBUX ) is closing regional offices in Chicago, Atlanta, Dallas, and Burbank, California. After setting a 15-month high on Thursday, shares are fractionally lower at Friday’s open. More on Starbucks Starbucks: The Comeback Has Started But The Growth Story Is Not Proven Starbucks Earnings: Fully Caffeinated? Starbucks: This Undefeatable Coffee Champion Has Been Judged Beyond Logic Starbucks perks up after TD Cowen turns bullish Earnings Scorecard: 12 out of 15 S&P 500 consumer discretionary firms beat EPS estimates this week
Is Figma ( FIG ) finally showing signs of a comeback after months of brutal selling? The stock surged ~10% to $22.20 in Friday’s pre-market trading after posting stronger-than-expected Q1 results and raising guidance. Figma reported Q1 revenue of $333M, up 46% YoY and above analyst estimates of nearly $316M. Management said growth was driven by enterprise seat expansion, strong retention, and risi...
Is Figma ( FIG ) finally showing signs of a comeback after months of brutal selling? The stock surged ~10% to $22.20 in Friday’s pre-market trading after posting stronger-than-expected Q1 results and raising guidance. Figma reported Q1 revenue of $333M, up 46% YoY and above analyst estimates of nearly $316M. Management said growth was driven by enterprise seat expansion, strong retention, and rising adoption of AI tools like Figma Make and Figma Weave. The net dollar retention also improved to 139%, its highest level in more than two years, while free cash flow reached $89M. The company’s AI monetization strategy became a major focus for investors. CFO Praveer Melwani said Q2 will mark Figma’s first full quarter of AI credit monetization , with early trends already running ahead of expectations. Moreover, the firm also raised FY26 revenue guidance to $1.42B-$1.43B and lifted its non-GAAP operating income outlook by $25M. "Investor optimism was also supported by Figma’s growing positioning in enterprise AI workflows, highlighted through a recent collaboration-focused discussion with Google ( GOOG ) Cloud AI leadership." Despite the strong quarter, analysts remain cautious. According to Investing.com, RBC Capital Markets lowered its price target on Figma to $28 from $31 while maintaining a Sector Perform rating, reflecting concerns around competition, margin visibility, and long-term AI spending trends. Figma YTD price chart (TradingView) “The improving sentiment is also starting to reflect on the chart.” Technically, the stock is showing signs of recovery after rebounding from the $17-$18 support zone. RSI has improved to near 56, while MACD recently turned positive, signaling improving bullish momentum. However, the stock still faces major resistance around $23. A sustained breakout above $23 could strengthen bullish momentum and open room toward the $30 range. Even after today’s rally , the stock remains down 45.84% YTD, sharply lagging the S&P 500 ’s ( SP500 ) 9.5...
wirot pathi/iStock via Getty Images I previously rated Nebius Group ( NBIS ) as a Buy in February 2026, thanks to the improved risk/reward profile from the prior consolidation. In this article, I shall discuss why I am downgrading the stock to a Hold here, with the ongoing market rotation to the AI-related sector already triggering a minimal margin of safety. NBIS Proves Their AI Beneficiary Statu...
wirot pathi/iStock via Getty Images I previously rated Nebius Group ( NBIS ) as a Buy in February 2026, thanks to the improved risk/reward profile from the prior consolidation. In this article, I shall discuss why I am downgrading the stock to a Hold here, with the ongoing market rotation to the AI-related sector already triggering a minimal margin of safety. NBIS Proves Their AI Beneficiary Status NBIS 1Y Stock Price ( TradingView ) 1. Recovering AI Sentiment Since my last Buy rating, NBIS has delivered an outsized +115.9% stock price rally while outperforming the wider market at +9.1% and many of its diversified hyperscaler/neocloud peers by large degrees. Much of its tailwinds are attributed to numerous hyperscalers reiterating their multi-billion-dollar cloud spending trends in the Q1'26 earnings season, with their FY2027 capex also expected "to significantly increase compared to 2026 ." These may have contributed to the notable market rotation to stocks with " infrastructure-adjacent real assets " and "AI-enabled operating models," since these assets supposedly demonstrate "greater scalability and margin resilience," thanks to the ongoing compute supply/demand imbalance. These reasons may also be why a similar double-digit rally has been observed in the iShares U.S. Digital Infrastructure and Real Estate ETF ( IDGT ), with the ETF notably comprised of several data center REITs and even NBIS' competitor, CoreWeave ( CRWV ). 2. FQ1'26 Numbers Discussed The exuberance observed in NBIS' recent stock price action appears somewhat warranted as well, given the outsized FQ1'26 performance metrics across: the revenues of $399M ( +75.2% QoQ /+683.8% YoY), the adj. EBITDA of $129.5M (+763.3% QoQ/+341.1% YoY), and the adj. EBITDA margins of 32.4% (+25.9 percentage points QoQ/+37.9 YoY), with the ramping up compute/power capacity directly contributing to the AI business' annualized run rate revenue of $1.9B by the end of March 2026 (+52% QoQ). This is on top of their abilit...
Investing.com -- Samsung Electronics has entered emergency management mode as up to 50,000 employees prepare to strike for 18 days starting May 21, according to Mizuho TMT Sector Specialist Jordan Klein. The company has begun a "warm down" of its memory fabs at the Pyeongtaek facility to prevent equipment damage during a potential stoppage.
Investing.com -- Samsung Electronics has entered emergency management mode as up to 50,000 employees prepare to strike for 18 days starting May 21, according to Mizuho TMT Sector Specialist Jordan Klein. The company has begun a "warm down" of its memory fabs at the Pyeongtaek facility to prevent equipment damage during a potential stoppage.